Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anaptysbio (ANAB) Return on Invested Capital (2018 - 2025)

Anaptysbio's Return on Invested Capital history spans 6 years, with the latest figure at 0.77% for Q3 2025.

  • For Q3 2025, Return on Invested Capital rose 114.0% year-over-year to 0.77%; the TTM value through Sep 2025 reached 0.77%, up 114.0%, while the annual FY2024 figure was 1.45%, 125.0% down from the prior year.
  • Return on Invested Capital reached 0.77% in Q3 2025 per ANAB's latest filing, down from 16.09% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 16.09% in Q2 2025 to a low of 1.91% in Q1 2025.
  • Average Return on Invested Capital over 3 years is 1.4%, with a median of 0.42% recorded in 2024.
  • The largest YoY upside for Return on Invested Capital was 1721bps in 2025 against a maximum downside of -144bps in 2025.
  • A 3-year view of Return on Invested Capital shows it stood at 0.33% in 2023, then plummeted by -349bps to 1.48% in 2024, then soared by 152bps to 0.77% in 2025.
  • Per Business Quant, the three most recent readings for ANAB's Return on Invested Capital are 0.77% (Q3 2025), 16.09% (Q2 2025), and 1.91% (Q1 2025).